StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)

Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –

AtriCure operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

AtriCure's operating cash flow for the twelve months ending Jun 30, 2026 was $64.94M, up 78.3% year over year. For fiscal 2025 it was $57.33M, up 369.8% from the year before. The highest annual figure on record is $57.33M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$57.33M+369.8%
FY2024Dec 31, 2024$12.20M+172.2%
FY2023Dec 31, 2023$4.48M–
FY2022Dec 31, 2022-$22.14M–
FY2021Dec 31, 2021-$13.78M–
FY2020Dec 31, 2020-$19.87M–
FY2019Dec 31, 2019-$15.81M–
FY2018Dec 31, 2018-$4.17M–
FY2017Dec 31, 2017-$8.94M–
FY2016Dec 31, 2016-$15.12M–
FY2015Dec 31, 2015-$7.84M–
FY2014Dec 31, 2014-$21.60M–
FY2013Dec 31, 2013-$5.22M–
FY2012Dec 31, 2012-$1.94M–
FY2011Dec 31, 2011-$1.99M–
FY2010Dec 31, 2010-$33.00K-107.9%
FY2009Dec 31, 2009$419.95K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.19M+2.7%
Q1 FY2026Mar 31, 2026-$4.00M–
Q4 FY2025Dec 31, 2025$20.03M+243.2%
Q3 FY2025Sep 30, 2025$26.72M+33.6%
Q2 FY2025Jun 30, 2025$21.62M+192.9%
Q1 FY2025Mar 31, 2025-$11.03M–
Q4 FY2024Dec 31, 2024$5.84M+44.8%
Q3 FY2024Sep 30, 2024$20.00M+1214.3%
Q2 FY2024Jun 30, 2024$7.38M+145.1%
Q1 FY2024Mar 31, 2024-$21.02M–
Q4 FY2023Dec 31, 2023$4.03M+8660.9%
Q3 FY2023Sep 30, 2023$1.52M–
Q2 FY2023Jun 30, 2023$3.01M-28.8%
Q1 FY2023Mar 31, 2023-$4.08M–
Q4 FY2022Dec 31, 2022$46.00K-84.7%
Q3 FY2022Sep 30, 2022-$1.78M–
Q2 FY2022Jun 30, 2022$4.23M–
Q1 FY2022Mar 31, 2022-$24.63M–
Q4 FY2021Dec 31, 2021$301.00K-92.4%
Q3 FY2021Sep 30, 2021-$232.00K-106.1%
Q2 FY2021Jun 30, 2021-$4.53M–
Q1 FY2021Mar 31, 2021-$9.32M–
Q4 FY2020Dec 31, 2020$3.95M–
Q3 FY2020Sep 30, 2020$3.81M–
Q2 FY2020Jun 30, 2020-$11.55M-408.3%
Q1 FY2020Mar 31, 2020-$16.09M–
Q4 FY2019Dec 31, 2019-$3.53M-458.3%
Q3 FY2019Sep 30, 2019-$2.59M-149.7%
Q2 FY2019Jun 30, 2019$3.75M–
Q1 FY2019Mar 31, 2019-$13.44M–
Q4 FY2018Dec 31, 2018$985.00K-35.5%
Q3 FY2018Sep 30, 2018$5.21M+3879.4%
Q2 FY2018Jun 30, 2018-$935.00K–
Q1 FY2018Mar 31, 2018-$9.43M–
Q4 FY2017Dec 31, 2017$1.53M+100.8%
Q3 FY2017Sep 30, 2017$131.00K-87.8%
Q2 FY2017Jun 30, 2017-$1.06M–
Q1 FY2017Mar 31, 2017-$9.55M–
Q4 FY2016Dec 31, 2016$761.00K–
Q3 FY2016Sep 30, 2016$1.08M–

More AtriCure figures

See a number that looks wrong?